novo nordisk ozempic - Search News

News

Ozempic, FDA

USA TODAY · 2d

Drugmaker Novo Nordisk warns consumers about counterfeit versions of Ozempic in US

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in the United States.

New York Post · 16h

Fake Ozempic drugs found in US drug supply, FDA warns

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg” were in the US drug supply chain.

Health News Florida · 21h

The FDA warns patients about counterfeit Ozempic that may be in circulation

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug that made it onto the market outside the company's approved supply chain.

Weight Loss, Ozempic

The New York Times · 41m

Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with other injectable GLP-1 weight loss drugs, such as Lilly’s Mounjaro and Novo Nordisk’s Ozempic.

The Detroit News · 2h

Lilly soars after weight-loss pill results rival Ozempic’s

Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.

3hon MSN

Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade

U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral ...

2h

Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock

The analyst highlights that Lilly’s drugs, Mounjaro and Zepbound, will likely keep gaining U.S. market share from Novo ...

Ozempic, Mounjaro mania: Can employers afford the weight-loss revolution?

Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.

1don MSN

Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...

3d

Pfizer just had a big setback in its race for an Ozempic competitor

Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a ...

3d

Parker Waichman LLP Represents Victim Diagnosed With NAION After Using Ozempic

National Law Firm Filed One of the First Eye Injury Cases against Novo Nordisk in the Superior Court of New Jersey, Middlesex County PORT W ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results